DURHAM, N.C., Sept. 22, 2010 (GLOBE NEWSWIRE) -- Patrick S. Smith, President and Chief Executive Officer of Curaxis Pharmaceutical Corp. (OTCBB:CURX) at www.curaxispharma.com , announced today that it has signed a $25 million equity line agreement with Southridge Partners, II ("Southridge"), an institutional investor.
